Liraglutide
12 NDCs across 5 manufacturers|9 Generic,3 Brand
▸ More about this market▾ Less
The brand product was first FDA-approved on Jan 25, 2010, and the first generic was approved Dec 23, 2024. In 2024, Medicare Part D spent $329 million on Liraglutide across 352,000 claims for 128,000 beneficiaries.
Liraglutide is available as 12 NDCs from 5 manufacturers (9 generic, 3 brand), with NADAC prices from $30.63 to $87.82 per ML — the most expensive product costs about 2.9× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Active FDA drug shortage
9 Liraglutide presentations are currently listed in FDA's drug shortage database (first posted Jul 18, 2023). Shortages can move NADAC prices in the following weeks.
Total NDCs
12
9G / 3B
Manufacturers
5
competing in market
Price Spread
$30.63 – $87.82
per ML
7d Activity
avg -3.5% WoW · of 12 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Novo Nordisk manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
GLP-1 Receptor Agonist class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
5 manufacturers producing LIRAGLUTIDE(1 pricing outlier)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
VICTOZA 3-PAK 18 MG/3 ML PEN | $87.8196 per ML | +0.01% |
VICTOZA 2-PAK 18 MG/3 ML PEN | $87.7480 per ML | +0.01% |
SAXENDA 18 MG/3 ML PEN | $87.1260 per ML | -0.01% |
LIRAGLUTIDE 5-PAK 18 MG/3 ML | $49.2481 per ML | +3.26% |
LIRAGLUTIDE 2-PAK 18 MG/3 ML | $31.4062 per ML | -7.13% |
LIRAGLUTIDE 2-PAK 18 MG/3 ML | $31.4062 per ML | -7.13% |
LIRAGLUTIDE 2-PAK 18 MG/3 ML | $31.4062 per ML | -7.13% |
LIRAGLUTIDE 2-PAK 18 MG/3 ML | $31.4062 per ML | -7.13% |
LIRAGLUTIDE 3-PAK 18 MG/3 ML | $30.6324 per ML | -4.28% |
LIRAGLUTIDE 3-PAK 18 MG/3 ML | $30.6324 per ML | -4.28% |
LIRAGLUTIDE 3-PAK 18 MG/3 ML | $30.6324 per ML | -4.28% |
LIRAGLUTIDE 3-PAK 18 MG/3 ML | $30.6324 per ML | -4.28% |
Frequently Asked Questions
When did Liraglutide become available as a generic?
FDA approved the first generic Liraglutide (ANDA) on Dec 23, 2024.
How much does Medicare spend on Liraglutide?
In 2024, Medicare Part D spent $329 million on Liraglutide across 352,000 claims for 128,000 beneficiaries.
Is Liraglutide in shortage?
Yes — FDA's drug shortage database currently lists 9 Liraglutide presentations with status "Current", first posted Jul 18, 2023.
How many Liraglutide products are on the market?
The Liraglutide drug market contains 12 NDCs from 5 manufacturers — 9 generic and 3 brand products.
What is the price range for Liraglutide?
NADAC reference prices for Liraglutide range from $30.6324 to $87.8196 per ML — the most expensive product costs about 2.9× the cheapest.
Is generic Liraglutide cheaper than brand?
The average generic NADAC for Liraglutide is $33.0447 per ML, versus $87.5645 for brand-labeled products — brand versions average about 2.6× the generic price.
Which manufacturers make Liraglutide?
5 manufacturers list Liraglutide in NADAC. Ranked by number of NDCs, the largest are Novo Nordisk (3), Teva Pharmaceuticals USA Inc. (3), Hikma Pharmaceuticals USA Inc. (2), Lupin Pharmaceuticals Inc. (2), Meitheal Pharmaceuticals Inc. (2).
How has the price of Liraglutide changed recently?
Over the past 7 days, 3 Liraglutide NDCs rose and 9 fell, with a market-wide average change of -3.5%.